Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2010
05/06/2010US20100112693 Differentiation of Human Embryonic Stem Cells
05/06/2010US20100112692 Differentiation of Human Embryonic Stem Cells
05/06/2010US20100112691 Stem Cell Aggregate Suspension Compositions and Methods of Differentiation Thereof
05/06/2010US20100112690 Insert device for multiwell plate
05/06/2010US20100112689 Method of obtaining viable human cells, including hepatic stem/progenitor cells
05/06/2010US20100112688 Screening Methods for Compounds that Modulate the Activity of G-Protein Coupled Receptors
05/06/2010US20100112687 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
05/06/2010US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
05/06/2010US20100112672 Production of isoprenoids and isoprenoid precursors
05/06/2010US20100112666 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them
05/06/2010US20100112648 (r)-hydroxynitrile lyase from brassicaceae
05/06/2010US20100112635 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
05/06/2010US20100112616 NOVEL BETA-GALACTOSIDE-a2,6-SIALYLTRANSFERASE, A GENE ENCODING THEREOF, AND A METHOD FOR ENHANCING ENZYME ACTIVITY
05/06/2010US20100112608 Method of diagnosing lawsonia intracellularis
05/06/2010US20100112602 Protein-Protein Interaction Biosensors and Methods of Use Thereof
05/06/2010US20100112600 Methods and compositions for modulating synapse formation
05/06/2010US20100112591 Tumor Suppressor Gene
05/06/2010US20100112587 Transcriptomic biomarkers for individual risk assessment in new onset heart failure
05/06/2010US20100112543 Processing soft tissue, methods and compositions related thereto
05/06/2010US20100112182 Cotton variety 06t201f
05/06/2010US20100112087 Oxygen-generating compositions for enhancing cell and tissue survival in vivo
05/06/2010US20100112084 Method and apparatus for increasing adipose vascular fraction
05/06/2010US20100112080 MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN
05/06/2010US20100112067 Compositions and methods for biological remodeling with frozen particle compositions
05/06/2010US20100112062 Kidney structures and methods of forming the same
05/06/2010US20100112038 Methods of treating neurological conditions with hematopoeitic growth factors
05/06/2010US20100112031 Compositions And Methods For Regulating Extracellular Matrix Production In Adipose Derived Cells
05/06/2010US20100112030 Role of hedgehog signaling in atherosclerosis and cardiovascular disease
05/06/2010US20100112026 Surfaces, methods and devices employing cell rolling
05/06/2010US20100112000 Non-tumorigenic mdck cell line for propagating viruses
05/06/2010US20100111993 Recombinant vaccines and use thereof
05/06/2010US20100111992 Cytomegalovirus peptides and methods of use thereof
05/06/2010US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
05/06/2010US20100111988 Small peptide for anti-angiogenesis and use thereof
05/06/2010US20100111987 Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
05/06/2010US20100111984 Nanospheres encapsulating bioactive material and method for formulation of nanospheres
05/06/2010US20100111982 Rheumatoid arthritis t cell vaccine
05/06/2010US20100111979 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/06/2010US20100111977 Methods and compositions for treatment of myotonic dystrophy
05/06/2010US20100111975 Monoclonal Antibodies for Treatment of Cancer
05/06/2010US20100111964 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
05/06/2010US20100111958 Notch-Binding Agents and Antagonists and Methods of Use Thereof
05/06/2010US20100111955 Hedgehog signaling pathway proteins and uses thereof
05/06/2010US20100111953 Antibodies that immunospecifically bind to b lymphocyte stimulator
05/06/2010US20100111952 Treatment of autoimmune disorders
05/06/2010US20100111951 ADAM-9 Modulators
05/06/2010US20100111943 Compositions and methods for inhibiting cancer metastasis
05/06/2010US20100111938 Compositions and methods for biological remodeling with frozen particle compositions
05/06/2010US20100111931 Agents, Which Inhibit Apoptosis in Cells that are Involved in Wound Healing
05/06/2010US20100111925 Compositions of Engineered Human Arginases and Methods for Treating Cancer
05/06/2010US20100111924 Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site
05/06/2010US20100111922 Animal model and use of 17beta-hydroxysteroid dehydrogenase type 7 in the diagnosis of anencephaly
05/06/2010US20100111917 Cell-adhesive polyelectrolyte material for use as membrane and coating
05/06/2010US20100111916 Materials and Method of Modulating the Immune Response
05/06/2010US20100111914 Stem cells from urine and methods for using the same
05/06/2010US20100111913 Method of enhancing migration of neural precursor cells
05/06/2010US20100111910 Treatment of excessive neovascularization
05/06/2010US20100111909 Dedifferentiation of Adult Mammalian Cardiomyocytes into Cardiac Stem Cells
05/06/2010US20100111908 Induction of Renal Cells for Treatment of Kidney Disease
05/06/2010US20100111907 Methods and compositions for gene inactivation
05/06/2010US20100111901 Triazole inhibitors of aromatase
05/06/2010US20100111900 Heterocyclic antiviral compounds
05/06/2010US20100111868 Monoclonal antibodies for neutralizing anthrax toxin
05/06/2010US20100111855 Frozen compositions and methods for piercing a substrate
05/06/2010US20100111848 Compositions and methods for administering compartmentalized frozen particles
05/06/2010US20100111847 Compositions and methods for administering compartmentalized frozen particles
05/06/2010US20100111837 Compositions and methods for biological remodeling with frozen particle compositions
05/06/2010US20100111836 Compositions and methods for therapeutic delivery with frozen particles
05/06/2010US20100107473 Enhancement of cold tolerance in plants
05/06/2010CA2742268A1 Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
05/06/2010CA2742267A1 Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
05/06/2010CA2741793A1 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53
05/06/2010CA2741426A1 Method and device for activating stem cells
05/05/2010EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
05/05/2010EP2182059A1 Rapidly degraded reporter fusion proteins
05/05/2010EP2182055A1 Human cord blood derived unrestricted somatic stem cells (USSC)
05/05/2010EP2182054A1 Process for identification and isolation of mesenchymal cells with marked bone regenerative ability
05/05/2010EP2182053A1 A combination comprising a magnet and a magnetic cell
05/05/2010EP2182052A1 Human foreskin cells suitable for culturing stem cells
05/05/2010EP2182051A1 Transformants capable of producing isopropanol
05/05/2010EP2182003A1 Peptide capable of binding to immunoglobulin
05/05/2010EP2181193A1 Nanocarrier based plant transfection and transduction
05/05/2010EP1790655B1 Biologically active peptides
05/05/2010EP1730198B1 Adzymes and uses thereof
05/05/2010EP1648520B1 Compounds and methods for downregulating the effects of tgf-beta
05/05/2010EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
05/05/2010EP1427817B1 Multiplication of viruses in a cell culture
05/05/2010EP1248803B1 Nogo receptor-mediated blockade of axonal growth
05/05/2010EP0973928B1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell
05/05/2010EP0935648B1 Improved adenovirus vectors
05/05/2010EP0854917B1 Transgenic non-human animals capable of producing heterologous antibodies
05/05/2010CN1816624B Rice transposon gene
05/05/2010CN1778905B Separating culture and use for fatty mesenchymal dry cell
05/05/2010CN1768136B Agar-digesting enzyme and utilization thereof
05/05/2010CN1752104B Monoclonal antibody of synapse protein gamma and its application
05/05/2010CN1733924B A method for regulating plant lignin content
05/05/2010CN1630526B Systems and methods for treating patients with processed lipoaspirate cells
05/05/2010CN1446261B Modified cytokines for use in cancer therapy
05/05/2010CN1387572B Plant reglatory sequences for selective control of gene expression
05/05/2010CN1376204B Flex seed specific promoters
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 1827